{"cik":1997296,"taxonomy":"us-gaap","tag":"InterestExpense","label":"Interest Expense","description":"Amount of the cost of borrowed funds accounted for as interest expense.","entityName":"MEDICUS PHARMA LTD.","units":{"USD":[{"start":"2025-01-01","end":"2025-03-31","val":0,"accn":"0001062993-26-002629","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-14","frame":"CY2025Q1"},{"start":"2025-01-01","end":"2025-06-30","val":0,"accn":"0001062993-26-004230","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-12"},{"start":"2025-04-01","end":"2025-06-30","val":0,"accn":"0001062993-26-004230","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-12","frame":"CY2025Q2"},{"start":"2026-01-01","end":"2026-03-31","val":374712,"accn":"0001062993-26-002629","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-14","frame":"CY2026Q1"},{"start":"2026-01-01","end":"2026-06-30","val":523789,"accn":"0001062993-26-004230","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-12"},{"start":"2026-04-01","end":"2026-06-30","val":205638,"accn":"0001062993-26-004230","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-12","frame":"CY2026Q2"}]}}